| Recruiting | FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer | Phase 1 | 2025-11-04 |
| Recruiting | A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Systemic Sclerosis (SSc) | Phase 1 | 2024-03-28 |
| Recruiting | FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2024-01-05 |
| Completed | FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101) Relapsed/Refractory B-Cell Lymphoma | Phase 1 | 2023-11-16 |
| Withdrawn | FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma | Phase 1 | 2022-12-01 |
| Terminated | FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer | Phase 1 | 2022-05-31 |
| Completed | FT576 in Subjects With Multiple Myeloma Multiple Myeloma, Myeloma | Phase 1 | 2021-11-10 |
| Terminated | FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors Solid Tumor, Adult | Phase 1 | 2021-10-15 |
| Active Not Recruiting | FT819 in Subjects With B-cell Malignancies Lymphoma, B-Cell, Chronic Lymphocytic Leukemia, Precursor B-Cell Acute Lymphoblastic Leukemia | Phase 1 | 2021-07-12 |
| Terminated | FT538 in Subjects With Advanced Hematologic Malignancies Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma | Phase 1 | 2020-10-17 |
| Terminated | FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors Solid Tumor, Adult | Phase 1 | 2020-09-07 |
| Terminated | FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies Lymphoma, B-Cell, Chronic Lymphocytic Leukemia | Phase 1 | 2020-03-19 |
| Terminated | Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy Hematological Malignancy | — | 2019-10-04 |
| Terminated | FT516 in Subjects With Advanced Hematologic Malignancies Acute Myelogenous Leukemia, B-cell Lymphoma | Phase 1 | 2019-10-04 |
| Terminated | Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular I Advanced Solid Tumor, Lymphoma, Gastric Cancer | — | 2019-06-11 |
| Completed | FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumo Advanced Solid Tumors, Lymphoma, Gastric Cancer | Phase 1 | 2019-02-15 |
| Completed | FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors HER2 Positive Gastric Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 | 2018-01-18 |
| Completed | Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies Hematologic Malignancies, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2016-12-20 |
| Terminated | A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders Metabolic Disorders | Phase 1 | 2015-06-01 |
| Terminated | A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies Hematologic Malignancies | Phase 1 | 2014-12-01 |
| Terminated | The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant Hematologic Malignancies | Phase 2 | 2012-07-01 |
| Completed | Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease, Chronic Lymphocytic Leukemia (CLL) | Phase 1 | 2012-01-01 |
| Completed | Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. Hematologic Malignancies, Allogeneic Stem Cell Transplantation | Phase 1 | 2011-01-01 |